# Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea

> **NCT05027516** · PHASE4 · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 42 (actual)

## Conditions studied

- Neisseria Gonorrhoeae

## Interventions

- **DRUG:** Rocephin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT05027516
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-17
- **Primary completion:** 2022-05-09
- **Final completion:** 2022-05-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027516, "Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05027516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*